Vaccine News and Research

Latest Vaccine News and Research

Meta-analysis on COVID-19 vaccine effectiveness in association with antibody titers

Researchers performed a meta-analysis analyzing randomized controlled trials (RCTs) that evaluated the effectiveness of coronavirus disease 2019 (COVID-19) vaccines, and the dose-response association of humoral responses with vaccine effectiveness.

6 Mar 2023

Messages about the cardiovascular benefits of flu vaccination boost vaccine uptake

Making a connection between the flu and the risk of subsequent heart problems significantly increased flu vaccination rates among older Danish adults, according to a study presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology. A reminder message the day before the start of a national vaccine program also helped "nudge" people to get vaccinated.

5 Mar 2023

Confronting anti-vaccine activism by disseminating accurate narratives on life-saving benefits of vaccines

Public and private sector health officials and public policymakers should team up immediately with community leaders to more effectively disseminate accurate narratives regarding the life-saving benefits of vaccines to counter widespread, harmful misinformation from anti-vaccine activists.

3 Mar 2023

Naked mRNA delivered using needle-free PYRO injection presents a safe and effective potential vaccination method

Researchers examined the vaccination effects and local antigen expression efficiency of a needle-free vaccination technique involving pyro-drive liquid jet injection (PYRO) to deliver the naked messenger ribonucleic acid (mRNA) to the skin.

3 Mar 2023

Engineering epitope scaffolds of conserved regions of SARS-CoV-2 spike

In a recent study posted to the bioRxiv* preprint server, researchers engineered epitope scaffolds (ESs) of conserved regions of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.

3 Mar 2023

Does the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination vary by age, sex, and inter-dose interval among adolescents aged 12 to 17?

Researchers conducted a population-based cohort study among 12 to 17-year-old adolescents in Ontario, Canada, to estimate the incidence of myocarditis or pericarditis after BNT162b2 vaccination.

3 Mar 2023

Large-scale longitudinal study of neutralizing antibody responses to norovirus in children

Researchers characterized serological neutralizing antibody responses to norovirus among young children, transitioning between sequential GII.4 pandemic strains, DH 2006, NO 2009, and SY 2012.

3 Mar 2023

Cirrhosis associated with lower immune responses to COVID-19 vaccines in patients with chronic liver disease

The overall responsiveness of patients with chronic liver disease (CLD) to COVID-19 vaccines has been shown to be decreased in patients with cirrhosis.

2 Mar 2023

Serious pneumococcal infection increases the risk of a heart attack significantly

After the onset of serious pneumococcal infections, patients are at a significantly increased risk of having a heart attack, according to a Vanderbilt study published in the journal Clinical Infectious Diseases.

2 Mar 2023

Reprogrammed tumor cells could teach the body's immune system to fight cancer

Some cities fight gangs with ex-members who educate kids and starve gangs of new recruits. Stanford Medicine researchers have done something similar with cancer — altering cancer cells so that they teach the body's immune system to fight the very cancer the cells came from.

2 Mar 2023

Using a mathematical model for future pandemic preparedness

Scientists have developed mathematical models that analyze the data obtained from an initial wave of the influenza pandemic to predict the dynamics of subsequent waves. Such predictions could be useful for pandemic preparedness.

2 Mar 2023

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

COVID-19 vaccine inequity exists within and between countries, which impacted disease burden and mortality.

1 Mar 2023

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Omicron BTIs induce durable neutralizing immune responses by recalling cross-reactive and vaccine-induced memory B lymphocytes.

1 Mar 2023

Bacteria exploit nerve cells in the meninges to facilitate brain invasion

A new study led by researchers at Harvard Medical School details the step-by-step cascade that allows bacteria to break through the brain's protective layers - the meninges - and cause brain infection, or meningitis, a highly fatal disease.

1 Mar 2023

Covid-19 vaccination can curb the effect of long COVID on patients' social, professional, and family lives

Vaccination against SARS-CoV-2, the virus responsible for COVID-19, may lessen the severity and duration of 'long COVID' in those with persistent symptoms after infection, suggests a study that closely imitates a randomized clinical trial, and published in the open access journal, BMJ Medicine.

1 Mar 2023

Product development and drug delivery at Seda

In this interview, NewsMedical speaks with Shanoo about her career progression and role in Seda Pharmaceutical regarding product development and drug delivery. She also outlines some of the services that Seda offers.

From Seda Pharmaceutical Development Services 1 Mar 2023

Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2

In a recent study published in the journal Vaccines, researchers in Saudi Arabia and the United States examined immune responses and immunoglobulin G (IgG) cross-reactivity in individuals infected with Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Feb 2023

New solutions to boost Africa’s vaccine production

The COVID-19 pandemic has highlighted the importance of vaccines in controlling infectious disease in sub-Saharan Africa and renewed interest in vaccine research and development across the continent.

28 Feb 2023

The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

Researchers evaluated SARS-CoV-2 seroprevalence and population-level humoral immunity among Finnish individuals between April 2020 and December 2022.

28 Feb 2023

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

Researchers immunophenotyped T lymphocyte responses among unvaccinated individuals, representative of the entire spectrum of the clinical presentation of COVID-19.

28 Feb 2023

Previous
1
...
85
86
87
88
89
90
91
...
1122
Next

Vaccine News and Research

Latest Vaccine News and Research

Meta-analysis on COVID-19 vaccine effectiveness in association with antibody titers

Messages about the cardiovascular benefits of flu vaccination boost vaccine uptake

Confronting anti-vaccine activism by disseminating accurate narratives on life-saving benefits of vaccines

Naked mRNA delivered using needle-free PYRO injection presents a safe and effective potential vaccination method

Engineering epitope scaffolds of conserved regions of SARS-CoV-2 spike

Does the incidence of reported myocarditis or pericarditis after BNT162b2 vaccination vary by age, sex, and inter-dose interval among adolescents aged 12 to 17?

Large-scale longitudinal study of neutralizing antibody responses to norovirus in children

Cirrhosis associated with lower immune responses to COVID-19 vaccines in patients with chronic liver disease

Serious pneumococcal infection increases the risk of a heart attack significantly

Reprogrammed tumor cells could teach the body's immune system to fight cancer

Using a mathematical model for future pandemic preparedness

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

SARS-CoV-2 BA.1 and BA.2 breakthrough infections likely protect against BA.4 infection

Bacteria exploit nerve cells in the meninges to facilitate brain invasion

Covid-19 vaccination can curb the effect of long COVID on patients' social, professional, and family lives

Product development and drug delivery at Seda

Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2

New solutions to boost Africa’s vaccine production

The effects of Omicron emergence on seroprevalence and hybrid immunity in the Finnish adult population

Critical COVID-19 infection characterized by a shift from naïve T cell phenotypes to an expansion of cytotoxic CD4+ T lymphocyte subsets

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in